Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

New synthesis technology of anti-cancer drug Raltitrexed

A technology of raltitrexed and anticancer drugs, which is applied in the field of chemical synthesis of drugs, can solve the problems of difficult separation of monomethylated products, difficulty in controlling methylated products, and harsh reaction conditions, so as to achieve easy control of the reaction, Low cost and the effect of increasing the reaction temperature

Inactive Publication Date: 2011-07-20
深圳市普迈达科技有限公司
View PDF2 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] However, the former method needs to use reagents such as butyllithium, and the reaction conditions are harsh, the reaction time is long, and the production cost is high; the latter method has mild reaction conditions and is easy to operate, but in the N-methylation reaction process, it is difficult to control A single methylated product is obtained, and the separation of the monomethylated product is difficult, resulting in a very low yield

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New synthesis technology of anti-cancer drug Raltitrexed
  • New synthesis technology of anti-cancer drug Raltitrexed
  • New synthesis technology of anti-cancer drug Raltitrexed

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0052] 1. Synthesis of L-glutamic acid diethyl ester hydrochloride

[0053] Add 60 mL of freshly distilled anhydrous ethanol to a 100 mL three-neck flask connected with a spherical condenser (connected to the drying pipe and tail gas receiving device) and a constant pressure dropping funnel, and dissolve 26 mL of freshly distilled SOCl in an ice-salt bath at -10 to -15°C 2 (366mmol) was dropped into the system through a constant pressure dropping funnel for 0.5h, then warmed up to room temperature, and stirred for 3h. Add 8.8 g (56.2 mmol) of L-glutamic acid to the system, and react overnight at room temperature. Raise the temperature to 65°C, reflux for about 1.5 hours, and the insoluble white suspension turns into a light brown transparent liquid. The reaction is monitored by TLC, and the reaction is complete after 7 hours. Stop the reaction, quench, and distill off excess SOCl 2 and ethanol, solidified in an ice-water bath, and dried in an oven at 44°C for 9 hours to obta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a new synthesis technology of anti-cancer drug Raltitrexed. The technology comprises the following steps: 1) using L-glutamic acid as raw material to perform esterification with alcohol under the action of halogenating agent and obtain L-glutamic acid diester hydrochloride; 2) using 2-amino-5-methyl-benzoic acid as raw material to prepare 6-bromomethyl-3,4-dihydro-2-methyl-4-oxo-6-quinazoline through cyclization, amination and bromination; 3) using 2-thienyl-propanedioic acid as raw material to prepare N-[5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thenoyl]-L-glutamic acid diethyl ester through nitrification, esterification, reduction, amino protection, N-methylation and device-esterification; 4) using L-glutamic acid diester hydrochloride and N-[5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thenoyl]-L-glutamic acid diethyl ester to prepare N-[5-(N-methylamino)-2-thenoyl]-L-glutamic acid diester through dehydrant condensation and deamination protection; and 5) using N-[5-(N-methylamino)-2-thenoyl]-L-glutamic acid diester and 6-bromomethyl-3,4-dihydro-2-methyl-4-oxo-6-quinazoline to perform condensation under the catalysis of alkali, recycling preparative chromatography, purifying, and performing de-esterification to obtain Raltitrexed.

Description

technical field [0001] The invention relates to the field of chemically synthesized drugs, in particular to a new synthesis process of an anticancer drug raltitrexed. Background technique [0002] Colorectal cancer (CRC) is the second most common tumor in the world after lung cancer and is one of the leading causes of patient death. In the past 25 years, colorectal cancer has also become one of the two fastest growing malignant tumors in my country, with an increase of 100%. With the improvement of people's living standards and changes in eating habits, the incidence of colorectal cancer is increasing at a rate of 4.2% per year. It rose to 23.4 / 100,000 people in the early 1990s, and it has far exceeded this ratio. In Shanghai, which is more developed, the incidence rate of colorectal cancer is about 40 / 100,000, which is close to the level of western developed countries, and has risen from No. 6 to No. 2 in the ranking of tumor incidence. The number of patients suffering fr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D409/12A61P35/00
Inventor 贲腾裘式纶
Owner 深圳市普迈达科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products